Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3
Avalo Therapeutics' Abdakibart enters a pivotal hidradenitis suppurativa trial after positive LOTUS data, with monthly dosing and…
Myriam Alvarez NASDAQ
Avalo Therapeutics, Inc.
AVTX
1 story
$658M Market cap · 2026-10-21
Myriam Alvarez 